PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo.
Publication
, Conference
Hwang, B-J; Tsao, L-C; DeLeon, G; Wei, J; Yang, X-Y; Lei, G; Wang, T; Morse, MM; Lyerly, HK; Hartman, ZC
Published in: Cancer Immunology Research
March 1, 2020
Duke Scholars
Published In
Cancer Immunology Research
EISSN
2326-6074
ISSN
2326-6066
Publication Date
March 1, 2020
Volume
8
Issue
3
Start / End Page
53 / 54
Publisher
AMER ASSOC CANCER RESEARCH
Related Subject Headings
- 1115 Pharmacology and Pharmaceutical Sciences
- 1112 Oncology and Carcinogenesis
- 1107 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Hwang, B.-J., Tsao, L.-C., DeLeon, G., Wei, J., Yang, X.-Y., Lei, G., … Hartman, Z. C. (2020). PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo. In Cancer Immunology Research (Vol. 8, pp. 53–54). AMER ASSOC CANCER RESEARCH.
Hwang, Bin-Jin, Li-Chung Tsao, Gabriel DeLeon, Junping Wei, Xiao-Yi Yang, Gangjun Lei, Tao Wang, Michael M. Morse, Herbert Kim Lyerly, and Zachary Conrad Hartman. “PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo.” In Cancer Immunology Research, 8:53–54. AMER ASSOC CANCER RESEARCH, 2020.
Hwang B-J, Tsao L-C, DeLeon G, Wei J, Yang X-Y, Lei G, et al. PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo. In: Cancer Immunology Research. AMER ASSOC CANCER RESEARCH; 2020. p. 53–4.
Hwang, Bin-Jin, et al. “PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo.” Cancer Immunology Research, vol. 8, no. 3, AMER ASSOC CANCER RESEARCH, 2020, pp. 53–54.
Hwang B-J, Tsao L-C, DeLeon G, Wei J, Yang X-Y, Lei G, Wang T, Morse MM, Lyerly HK, Hartman ZC. PR2 Overexpression of MAVS stimulates antitumor immunity and significantly reduces tumor growth of immune-insensitive colorectal cancer in vivo. Cancer Immunology Research. AMER ASSOC CANCER RESEARCH; 2020. p. 53–54.
Published In
Cancer Immunology Research
EISSN
2326-6074
ISSN
2326-6066
Publication Date
March 1, 2020
Volume
8
Issue
3
Start / End Page
53 / 54
Publisher
AMER ASSOC CANCER RESEARCH
Related Subject Headings
- 1115 Pharmacology and Pharmaceutical Sciences
- 1112 Oncology and Carcinogenesis
- 1107 Immunology